219 related articles for article (PubMed ID: 28656542)
1. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.
Liu LCY; Valente MAE; Postmus D; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; van Veldhuisen DJ; Hillege HL; van der Meer P; Voors AA
Cardiovasc Drugs Ther; 2017 Jun; 31(3):281-293. PubMed ID: 28656542
[TBL] [Abstract][Full Text] [Related]
2. Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.
Demissei BG; Postmus D; Liu LCY; Cleland JG; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison BA; Edwards C; Givertz MM; Bloomfield DM; Dittrich HC; Voors AA; Hillege HL
Int J Cardiol; 2016 Nov; 223():967-975. PubMed ID: 27589047
[TBL] [Abstract][Full Text] [Related]
3. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
[TBL] [Abstract][Full Text] [Related]
4. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
[TBL] [Abstract][Full Text] [Related]
5. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Cotter G; Dittrich HC; Weatherley BD; Bloomfield DM; O'Connor CM; Metra M; Massie BM;
J Card Fail; 2008 Oct; 14(8):631-40. PubMed ID: 18926433
[TBL] [Abstract][Full Text] [Related]
6. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
Metra M; O'Connor CM; Davison BA; Cleland JG; Ponikowski P; Teerlink JR; Voors AA; Givertz MM; Mansoor GA; Bloomfield DM; Jia G; DeLucca P; Massie B; Dittrich H; Cotter G
Eur Heart J; 2011 Jun; 32(12):1519-34. PubMed ID: 21388992
[TBL] [Abstract][Full Text] [Related]
7. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
[TBL] [Abstract][Full Text] [Related]
8. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
Metra M; Mentz RJ; Chiswell K; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Lazzarini V; Mansoor GA; Massie BM; Ponikowski P; Teerlink JR; Voors AA; O'Connor CM
Eur J Heart Fail; 2015 Jan; 17(1):109-18. PubMed ID: 25431336
[TBL] [Abstract][Full Text] [Related]
9. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
[TBL] [Abstract][Full Text] [Related]
10. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
[TBL] [Abstract][Full Text] [Related]
11. The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
Teerlink JR; Iragui VJ; Mohr JP; Carson PE; Hauptman PJ; Lovett DH; Miller AB; Piña IL; Thomson S; Varosy PD; Zile MR; Cleland JG; Givertz MM; Metra M; Ponikowski P; Voors AA; Davison BA; Cotter G; Wolko D; Delucca P; Salerno CM; Mansoor GA; Dittrich H; O'Connor CM; Massie BM
Drug Saf; 2012 Mar; 35(3):233-44. PubMed ID: 22339573
[TBL] [Abstract][Full Text] [Related]
12. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
[TBL] [Abstract][Full Text] [Related]
13. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
Vegter EL; Schmitter D; Hagemeijer Y; Ovchinnikova ES; van der Harst P; Teerlink JR; O'Connor CM; Metra M; Davison BA; Bloomfield D; Cotter G; Cleland JG; Givertz MM; Ponikowski P; van Veldhuisen DJ; van der Meer P; Berezikov E; Voors AA; Khan MA
Int J Cardiol; 2016 Dec; 224():231-239. PubMed ID: 27661412
[TBL] [Abstract][Full Text] [Related]
14. A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
ter Maaten JM; Valente MA; Metra M; Bruno N; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; van Veldhuisen DJ; Hillege HL; Damman K; Voors AA
Clin Res Cardiol; 2016 Feb; 105(2):145-53. PubMed ID: 26280875
[TBL] [Abstract][Full Text] [Related]
15. HOTLINE III: End of the line for rolofylline?
Eur Heart J; 2009 Dec; 30(23):2819-20. PubMed ID: 19972641
[No Abstract] [Full Text] [Related]
16. Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function.
Ponikowski P; Mitrovic V; O'Connor CM; Dittrich H; Cotter G; Massie BM; Givertz MM; Chen E; Murray M; Weatherley BD; Fujita KP; Metra M
Eur J Heart Fail; 2010 Nov; 12(11):1238-46. PubMed ID: 20823097
[TBL] [Abstract][Full Text] [Related]
17. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M
Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185
[TBL] [Abstract][Full Text] [Related]
18. The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure.
de Boer RA; Cao Q; Postmus D; Damman K; Voors AA; Jaarsma T; van Veldhuisen DJ; Arnold WD; Hillege HL; Silljé HH
JACC Heart Fail; 2013 Apr; 1(2):164-9. PubMed ID: 24621840
[TBL] [Abstract][Full Text] [Related]
19. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
[TBL] [Abstract][Full Text] [Related]
20. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
